Search Results 261-270 of 24205 for B cell lymphomas

1. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

   The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies including large B- ...

2. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

   ... B-cell lymphoma (DLBCL). Tremelimumab and MEDI4736 will be tested with MEDI6469 in a set of subjects with advanced solid tumors while rituximab will be ...

3. Ernesto Ayala, M.D. - Doctors and Medical Staff - Mayo Clinic

   Acute lymphocytic leukemia · Acute myelogenous leukemia · B-cell lymphoma · Burkitt lymphoma · Follicular lymphoma · Graft versus host disease · Hodgkin lymphoma · Non ...

4. Hematology - Clinical trials

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

5. A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies - Mayo Clinic

   Participation eligibility · Diagnosis of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) as documented by medical records and with histology based on ...

6. Brentuximab (intravenous route) - Side effects & uses - Mayo Clinic

   Brentuximab injection is also used together with other medicines (eg, lenalidomide, rituximab) to treat certain types of large B-cell lymphoma (including ...

7. Hematology - Clinical trials

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

8. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

   ... lymphoma, Cutaneous t-cell lymphoma, B-cell l...ymphoma, Burkitt lymphoma, T-cell lymphoma, Follicular lymphoma, Sezary syndrome. Show more areas of focus ...

9. Hematology - Clinical trials

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

10. Mayo Clinic Transplant Center - Doctors

    D. Hematologist. Rochester, MN. Areas of focus: Bone marrow transplant, CAR-T cell therapy, Hodgkin lymphoma, Lymphoma, B-cell lymphoma, Burkitt lymphoma, ...